Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas
about
EBNA2 and activated Notch induce expression of BATFIdentification and characterization of a functional promoter region in the human eosinophil IL-5 receptor alpha subunit geneSearching in mother nature for anti-cancer activity: anti-proliferative and pro-apoptotic effect elicited by green barley on leukemia/lymphoma cellsProduction of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular cloneLysosomal enzymes in human lymphoblastoid lines: unusual characteristics of RAJI and DAUDI.Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytesEpstein-Barr virus provides a survival factor to Burkitt's lymphomas.CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitorsIdentification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expressionEstablishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines.Identification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells, and detection of antibodies in human seraCommon multigenic activation in different human neoplasias.Success of measles virotherapy in ATL depends on type I interferon secretion and responsiveness.The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell lineEpstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cellsEpstein-Barr virus genomes in lymphoid cells: activation in mitosis and chromosomal locationMALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes.Enteric bacteria promote human and mouse norovirus infection of B cells.Comparing proteomics and RISC immunoprecipitations to identify targets of Epstein-Barr viral miRNAs.A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses.Bidirectional transcription from the human immunoglobulin VH6 gene promoter.Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosisComparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro.Cellular target genes of Epstein-Barr virus nuclear antigen 2.Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell linesSinus-lining cells of the lymph nodes recognized as a dendritic cell type by the new monoclonal antibody Ki-M9.Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein.Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus SaimiriEBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latencySurface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cellsDetection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibodyIdentification of Epstein-Barr virus sequences that encode a nuclear antigen expressed in latently infected lymphocytesIn vitro induction of cytotoxic effector cells with spontaneous killer cell specificity.Association of the H-Y male antigen with beta2-microglobulin on human lymphoid and differentiated mouse teratocarcinoma cell lines.Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.Epstein-Barr virus susceptibility of normal human B lymphocyte populationsMonoclonal antibody against a Burkitt lymphoma-associated antigen.Nucleic acid spot hybridization: rapid quantitative screening of lymphoid cell lines for Epstein-Barr viral DNA.
P2860
Q24679432-BCC2A068-AC75-4315-9818-81547146BF69Q28306344-58BC758F-0701-465D-AB31-A4E17AD37D07Q28536983-8C6859F7-9BED-4B97-8247-3863286B8F25Q29547734-9096C1C8-A957-44D6-A7A2-18CFA16691BAQ31932947-075F1655-85CA-4D03-9CED-4D0FCE10713FQ33576126-0E4DB658-64EB-427A-927B-83A4344E5769Q33716529-7A6DF34E-D74A-4CE4-9385-ADA714630B0CQ33775064-962C8C98-17D1-482F-B98A-F98C0AE2EAFBQ33783532-6B8DE215-ED9D-4E6D-9A75-843AE540B4A6Q33866311-F9AB297C-A35B-4167-9357-F2AF7D23EB7AQ33905718-B9C1A325-7DFF-4701-97AC-D9427BE94D4EQ33933832-B3ED848C-A551-492F-ACB0-BACA5BF7F98BQ34053730-A4ECA433-C6EC-4483-AD4A-C089499A81B4Q34097631-070A9665-534E-4D41-9032-5245FB335FB7Q34339751-7FA319AE-50ED-4DB2-A182-79E27D54C6E3Q34366291-7710AE90-5382-4F65-A842-8B79997227F8Q34371715-66539D23-1F1F-4150-B934-4F758C6C83B4Q34432953-D11706FE-84ED-4DD4-B405-805B6315D929Q34446799-229245BD-58A1-4C46-BFEA-CB014A907D3BQ34455233-C6D22770-C637-4FD5-93CB-20095F70F1F7Q34547697-ED57F8EA-C3A5-4652-AEBB-E99734012FB8Q34809613-C7FCAE98-66F5-49FE-8988-3F37DF88D46AQ35077262-424CBD5B-B510-45F5-B217-C6FB71B25236Q35088713-09B9C4B3-3EEA-4296-AFA3-CCC149D81E5EQ35101342-D3AEE250-2896-4A8C-A580-58FC24339F4FQ35237788-97A4786E-A695-46BF-A19A-7C27A02026D7Q35763806-D5238BD2-A458-4708-9D2F-3DECC2680041Q35764932-AB4E3B78-3D04-4732-8EB9-764022748797Q35879209-E76F58D1-F8E3-4EC7-A848-86CD0DC9F915Q35932258-96ED5644-D89B-4331-B385-E5807961E221Q35982261-B89EEA42-098F-4C29-AA7B-2217014EACBDQ36135900-D3D8CC39-CD2F-4700-A123-B50DCC65E8F4Q36265053-9DA020B1-AC35-44E1-9E8F-7B56EA5D3E22Q36272248-12BCFF7C-BA92-4A8F-85BC-7C5B9831E3B7Q36340447-01961A5E-7552-4F1D-9B08-EE3BC0A81768Q36341692-AB912DEA-34BC-46B1-875B-0AE03545AFCBQ36343407-1E47E836-9DFD-41FB-9008-6A95E4929362Q36348358-B8E7B879-225C-4C1E-B4EB-2AECD288CDEBQ36376082-23E7E1E7-CDAC-4EBA-9D3C-B2F1EB39FD3BQ36416749-EFA9DBB5-F31C-4B53-B26B-44CB92E870CC
P2860
Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1974
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Continuous lymphoid cell lines ...... ved from three human lymphomas
@en
Continuous lymphoid cell lines ...... ed from three human lymphomas.
@nl
type
label
Continuous lymphoid cell lines ...... ved from three human lymphomas
@en
Continuous lymphoid cell lines ...... ed from three human lymphomas.
@nl
prefLabel
Continuous lymphoid cell lines ...... ved from three human lymphomas
@en
Continuous lymphoid cell lines ...... ed from three human lymphomas.
@nl
P2093
P2860
P4510
P356
P1476
Continuous lymphoid cell lines ...... ved from three human lymphomas
@en
P2093
P2860
P304
P356
10.1073/PNAS.71.8.3283
P407
P577
1974-08-01T00:00:00Z